-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
January 01, 2020 - Boyce (University
of Pittsburgh School of Medicine, Center for Pharmaceutical Policy and Prescribing
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal ASCVD
Risk Assessment Tool for Baseline 10-Year
ASCVD Risk
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857 …
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
February 01, 2018 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Baseline 10-
Year ASCVD Risk
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - This tool uses data value sets informed by the Center for Communicable Diseases (CDC) Guidelines for Prescribing